Cargando…
Super-enhancers: critical roles and therapeutic targets in hematologic malignancies
Super-enhancers (SEs) in a broad range of human cell types are large clusters of enhancers with aberrant high levels of transcription factor binding, which are central to drive expression of genes in controlling cell identity and stimulating oncogenic transcription. Cancer cells acquire super-enhanc...
Autores principales: | Jia, Yunlu, Chng, Wee-Joo, Zhou, Jianbiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636097/ https://www.ncbi.nlm.nih.gov/pubmed/31311566 http://dx.doi.org/10.1186/s13045-019-0757-y |
Ejemplares similares
-
Aberrant nuclear factor-kappa B activity in acute myeloid Leukemia: from molecular pathogenesis to therapeutic target
por: Zhou, Jianbiao, et al.
Publicado: (2015) -
Biological Hallmarks and Emerging Strategies to Target STAT3 Signaling in Multiple Myeloma
por: Zhou, Jianbiao, et al.
Publicado: (2022) -
Super-Enhancers Dysregulations in Hematological Malignancies
por: Belloucif, Yannis, et al.
Publicado: (2022) -
The Role of Signal Transducer and Activator of Transcription 3 (STAT3) and Its Targeted Inhibition in Hematological Malignancies
por: Arora, Loukik, et al.
Publicado: (2018) -
The emerging roles of exosomes in leukemogeneis
por: Zhou, Jianbiao, et al.
Publicado: (2016)